Skip to content
Top Globe News – Lifestyle
Author:
Splash Beverage Group
Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA-Regulated Pharmaceutical Development Program
July 29, 2026
Splash Beverage Group Announces Significant Balance Sheet Improvement and Board Approval of Reverse Stock Split as Company Continues Strategic Transformation
July 14, 2026
Splash Beverage Group Receives NYSE American Acceptance of Compliance Plan, Establishing Defined Path Toward Continued Listing and Strategic Transformation
July 9, 2026
Splash Beverage Group Provides Corporate Update on NYSE Compliance Process and Strategic Transaction Initiatives
June 3, 2026
Splash Beverage Group Receives NYSE Notice Regarding Shareholders’ Equity Requirement; will execute a plan to Regain Compliance
May 5, 2026